Cathie Wood and ARK Invest shift focus toward energy and biotech

Cathie Wood, CEO of ARK Invest, has executed significant trading maneuvers, shifting capital away from certain tech holdings toward the energy and biotechnology sectors. Recent activity shows a reduction in positions for companies including Palantir, Shopify, Teradyne, and Personalis.

In contrast, ARK has increased its investments in several growth-oriented areas. Notable purchases include X-energy and Oklo within the energy sector, as well as biotechnology firms such as Iambic Therapeutics, Scribe Therapeutics, and Freenome. The firm also added to its stake in CoreWeave, an AI infrastructure provider that has seen recent valuation corrections despite significant revenue growth.